Global Artemisinine Market Insights, Research, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 116

Report ID: 12076

Artemisinine is a drug derived from the Asian plant Artemisia annua. This aromatic plant has fern-like leaves and yellow flowers. For more than 2,000 years, it has been used to treat fevers. It's also an effective treatment for malaria.
The global Artemisinine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Artemisinine market based on company, product type, end user and key regions.

This report studies the global market size of Artemisinine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Artemisinine in these regions.
This research report categorizes the global Artemisinine market by top players/brands, region, type and end user. This report also studies the global Artemisinine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Guilin Pharmaceutical
Novanat Bioresource
KPC Pharmaceuticals
Guangxi xiancaotang
Natural Bio-engineering
Kerui nanhai

Market size by Product
Extraction from Artemisia annua
Semisynthetic Artemisinine
Market size by End User

Market size by Region
North America
United States
South Korea
Central & South America
Rest of Central & South America
Middle East & Africa
GCC Countries
South Africa

The study objectives of this report are:
To study and analyze the global Artemisinine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Artemisinine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Artemisinine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Artemisinine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Artemisinine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Artemisinine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Artemisinine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Artemisinine Market Size Growth Rate by Product
1.4.2 Extraction from Artemisia annua
1.4.3 Semisynthetic Artemisinine
1.5 Market by End User
1.5.1 Global Artemisinine Market Size Growth Rate by End User
1.5.2 Injections
1.5.3 Tablets
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Artemisinine Market Size
2.1.1 Global Artemisinine Revenue 2014-2025
2.1.2 Global Artemisinine Sales 2014-2025
2.2 Artemisinine Growth Rate by Regions
2.2.1 Global Artemisinine Sales by Regions
2.2.2 Global Artemisinine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Artemisinine Sales by Manufacturers
3.1.1 Artemisinine Sales by Manufacturers
3.1.2 Artemisinine Sales Market Share by Manufacturers
3.1.3 Global Artemisinine Market Concentration Ratio (CR5 and HHI)
3.2 Artemisinine Revenue by Manufacturers
3.2.1 Artemisinine Revenue by Manufacturers (2014-2019)
3.2.2 Artemisinine Revenue Share by Manufacturers (2014-2019)
3.3 Artemisinine Price by Manufacturers
3.4 Artemisinine Manufacturing Base Distribution, Product Types
3.4.1 Artemisinine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Artemisinine Product Type
3.4.3 Date of International Manufacturers Enter into Artemisinine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Artemisinine Sales by Product
4.2 Global Artemisinine Revenue by Product
4.3 Artemisinine Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Artemisinine Breakdown Data by End User

6 North America
6.1 North America Artemisinine by Countries
6.1.1 North America Artemisinine Sales by Countries
6.1.2 North America Artemisinine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Artemisinine by Product
6.3 North America Artemisinine by End User

7 Europe
7.1 Europe Artemisinine by Countries
7.1.1 Europe Artemisinine Sales by Countries
7.1.2 Europe Artemisinine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Artemisinine by Product
7.3 Europe Artemisinine by End User

8 Asia Pacific
8.1 Asia Pacific Artemisinine by Countries
8.1.1 Asia Pacific Artemisinine Sales by Countries
8.1.2 Asia Pacific Artemisinine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Artemisinine by Product
8.3 Asia Pacific Artemisinine by End User

9 Central & South America
9.1 Central & South America Artemisinine by Countries
9.1.1 Central & South America Artemisinine Sales by Countries
9.1.2 Central & South America Artemisinine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Artemisinine by Product
9.3 Central & South America Artemisinine by End User

10 Middle East and Africa
10.1 Middle East and Africa Artemisinine by Countries
10.1.1 Middle East and Africa Artemisinine Sales by Countries
10.1.2 Middle East and Africa Artemisinine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Artemisinine by Product
10.3 Middle East and Africa Artemisinine by End User

11 Company Profiles
11.1 Guilin Pharmaceutical
11.1.1 Guilin Pharmaceutical Company Details
11.1.2 Company Business Overview
11.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Guilin Pharmaceutical Artemisinine Products Offered
11.1.5 Guilin Pharmaceutical Recent Development
11.2.1 CAT KHANH Company Details
11.2.2 Company Business Overview
11.2.3 CAT KHANH Artemisinine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 CAT KHANH Artemisinine Products Offered
11.2.5 CAT KHANH Recent Development
11.3 Novanat Bioresource
11.3.1 Novanat Bioresource Company Details
11.3.2 Company Business Overview
11.3.3 Novanat Bioresource Artemisinine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novanat Bioresource Artemisinine Products Offered
11.3.5 Novanat Bioresource Recent Development
11.4 BEEPZ
11.4.1 BEEPZ Company Details
11.4.2 Company Business Overview
11.4.3 BEEPZ Artemisinine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 BEEPZ Artemisinine Products Offered
11.4.5 BEEPZ Recent Development
11.5 KPC Pharmaceuticals
11.5.1 KPC Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 KPC Pharmaceuticals Artemisinine Products Offered
11.5.5 KPC Pharmaceuticals Recent Development
11.6.1 BIONEXX Company Details
11.6.2 Company Business Overview
11.6.3 BIONEXX Artemisinine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 BIONEXX Artemisinine Products Offered
11.6.5 BIONEXX Recent Development
11.7 Guangxi xiancaotang
11.7.1 Guangxi xiancaotang Company Details
11.7.2 Company Business Overview
11.7.3 Guangxi xiancaotang Artemisinine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Guangxi xiancaotang Artemisinine Products Offered
11.7.5 Guangxi xiancaotang Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Company Business Overview
11.8.3 Sanofi Artemisinine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Sanofi Artemisinine Products Offered
11.8.5 Sanofi Recent Development
11.9 Natural Bio-engineering
11.9.1 Natural Bio-engineering Company Details
11.9.2 Company Business Overview
11.9.3 Natural Bio-engineering Artemisinine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Natural Bio-engineering Artemisinine Products Offered
11.9.5 Natural Bio-engineering Recent Development
11.10 Kerui nanhai
11.10.1 Kerui nanhai Company Details
11.10.2 Company Business Overview
11.10.3 Kerui nanhai Artemisinine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Kerui nanhai Artemisinine Products Offered
11.10.5 Kerui nanhai Recent Development

12 Future Forecast
12.1 Artemisinine Market Forecast by Regions
12.1.1 Global Artemisinine Sales Forecast by Regions 2019-2025
12.1.2 Global Artemisinine Revenue Forecast by Regions 2019-2025
12.2 Artemisinine Market Forecast by Product
12.2.1 Global Artemisinine Sales Forecast by Product 2019-2025
12.2.2 Global Artemisinine Revenue Forecast by Product 2019-2025
12.3 Artemisinine Market Forecast by End User
12.4 North America Artemisinine Forecast
12.5 Europe Artemisinine Forecast
12.6 Asia Pacific Artemisinine Forecast
12.7 Central & South America Artemisinine Forecast
12.8 Middle East and Africa Artemisinine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Artemisinine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer